Is Amgen Stock a Buy?

This biotech leader could be poised to rally higher.Amgen (AMGN -0.09%) stock is up 13% this year but has struggled to break out above a tight trading range in recent months. Despite a string of solid earnings reports from the biotechnology giant and Dow Jones Industrial Average component, pending clinical-trial data from its drug pipeline has added a layer of uncertainty.On the other hand, the company continues to deliver strong growth with overall positive fundamentals. So is now a good time to pick up so ...